BioSpace News Archive

Conference call and webcast (in English) to be held on November 12, 2020 at 2:00pm CET (1:00pm GMT/8:00am EST)

Esperion (NASDAQ: ESPR) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of Convertible Senior Subordinated Notes due 2025 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering

“A person’s HLA type is a piece of critical information needed for biologic drug safety research. We are now seeing a surge in demand for HLA-typed primary cells as researchers look to build ever-more predictive preclinical models for their personalized therapies.

Supernus Pharmaceuticals, Inc. announced that the Company’s management will present an overview and update, as well as host investor meetings, at the following virtual investor conferences in November 2020.

Report explores the impact of workplace wellness programs; alongside expert insights into how to deliver effective initiatives and measure return on investment (ROI)

Kodiak Sciences Inc. announced that a pre-recorded presentation of clinical study data on its investigational therapy KSI-301 is available at the American Academy of Ophthalmology 2020 Virtual Annual Meeting.